Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma

NCT05308901 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Melanoma, Uveal

Interventions

DRUG: Pembrolizumab
DRUG: Lenvatinib

Sponsor

Providence Health & Services

Collaborators

[object Object]
[object Object]